Granted Patent
Utility
US 4,220,660 · App. 05/967,000
Process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents
Inventor:
Norbert Brock
Patented Case
View Patent ↗
Granted: Sep 2, 1980
Filed: Dec 6, 1978
Inventor
Norbert Brock
Assignee (at issue)
Asta-Werke Aktiengesellschaft Chemische Fabrik
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.